Janssen Pharmaceuticals

J&J's Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules 'Not An Innovative Drug'

Cidara Therapeutics Stock Rises After Collaboration Agreement Janssen For Influenza Candidates

SpringWorks Therapeutics Stock Is Trading Higher After Nirogacestat Combo Study Starts Dosing In Multiple Myeloma Patients

Cidara Therapeutics Stock Rises After Collaboration Agreement Janssen For Influenza Candidates

SpringWorks Therapeutics Stock Is Trading Higher After Nirogacestat Combo Study Starts Dosing In Multiple Myeloma Patients

AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally

GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment

AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally

|

GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment

|

Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided'

|

Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug

|

Janssen Pharmaceuticals Recent News

Exclusive: Following Up Akebia, Johnson & Johnson's Research And License Agreement

|

Ladenburg On Biotech: Starts Achillion, Alnylam, Corcept, Trevana At Buy

|

Depomed Surges 8% Following NUCYNTA Acquisition From Janssen Pharmaceuticals

|

Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion

|